Glenmark Pharmaceuticals has informed that a meeting of the board of directors will be held on October 30, 2012, to consider and approve the company’s un-audited financial statements for the second quarter/half year ended September 30, 2012 (Q2).
The above information is a part of company's filings submitted to BSE.